ETV4 and prostate carcinoma: To identify signaling pathways required for the oncogenic function of ETS factors, a microarray analysis of ETV4 knockdown in PC3 prostate cancer cells [25] was compared to the Connectivity Map database [29] that contains microarray data of PC3 cells treated with 1309 small molecules, including many signaling pathway inhibitors.